Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

87 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Salvage treatment with paclitaxel and gemcitabine for patients with non-small-cell lung cancer after cisplatin- or docetaxel-based chemotherapy: a multicenter phase II study.
Androulakis N, Kouroussis C, Kakolyris S, Tzannes S, Papadakis E, Papadimitriou C, Geroyianni A, Georgopoulou T, Dimopoulou I, Souglakos J, Kotsakis A, Vardakis N, Hatzidaki D, Georgoulias V. Androulakis N, et al. Among authors: kouroussis c. Ann Oncol. 1998 Oct;9(10):1127-30. doi: 10.1023/a:1008497322508. Ann Oncol. 1998. PMID: 9834827 Free article. Clinical Trial.
Combination chemotherapy with docetaxel, vinorelbine and cisplatin as first-line treatment of advanced non-small-cell lung cancer: a multicenter phase II study of the Greek Cooperative Group for Lung Cancer.
Georgoulias V, Androulakis N, Bouros D, Kouroussis C, Chatzakis K, Papadakis M, Apostopoloulou F, Georgopoulou T, Kotsakis T, Souklakos J, Hatzidaki D, Vlachonikolis J, Panagos G. Georgoulias V, et al. Among authors: kouroussis c. Lung Cancer. 1998 Sep;21(3):213-20. doi: 10.1016/s0169-5002(98)00028-2. Lung Cancer. 1998. PMID: 9857999 Clinical Trial.
Docetaxel and granulocyte colony-stimulating factor in patients with advanced non-small-cell lung cancer previously treated with platinum-based chemotherapy: a multicenter phase II trial.
Alexopoulos K, Kouroussis C, Androulakis N, Papadakis E, Vaslamatzis M, Kakolyris S, Samelis G, Patila E, Vossos A, Samantas E, Georgoulias V. Alexopoulos K, et al. Among authors: kouroussis c. Cancer Chemother Pharmacol. 1999;43(3):257-62. doi: 10.1007/s002800050892. Cancer Chemother Pharmacol. 1999. PMID: 9923557 Clinical Trial.
Front-line treatment of advanced non-small-cell lung cancer with docetaxel and gemcitabine: a multicenter phase II trial.
Georgoulias V, Kouroussis C, Androulakis N, Kakolyris S, Dimopoulos MA, Papadakis E, Bouros D, Apostolopoulou F, Papadimitriou C, Agelidou A, Hatzakis K, Kalbakis K, Kotsakis A, Vardakis N, Vlachonicolis J. Georgoulias V, et al. Among authors: kouroussis c. J Clin Oncol. 1999 Mar;17(3):914-20. doi: 10.1200/JCO.1999.17.3.914. J Clin Oncol. 1999. PMID: 10071284 Clinical Trial.
Front-line treatment of metastatic breast cancer with docetaxel and epirubicin: a multicenter dose-escalation study. The Greek Breast Cancer Cooperative Group (GBCCG).
Kouroussis C, Xydakis E, Potamianou A, Giannakakis T, Kakolyris S, Agelaki S, Sara E, Malamos N, Alexopoulos A, Mavroudis D, Samonis G, Papadouris S, Georgoulias V, Panagos G. Kouroussis C, et al. Ann Oncol. 1999 May;10(5):547-52. doi: 10.1023/a:1026441804889. Ann Oncol. 1999. PMID: 10416004 Free article. Clinical Trial.
A dose escalation study of weekly docetaxel in patients with advanced solid tumors.
Kouroussis C, Agelaki S, Mavroudis D, Souglakos J, Kakolyris S, Kalbakis K, Vardakis N, Reppa D, Hatzidaki D, Samonis G, Georgoulias V. Kouroussis C, et al. Cancer Chemother Pharmacol. 2000;46(6):488-92. doi: 10.1007/s002800000184. Cancer Chemother Pharmacol. 2000. PMID: 11138462 Clinical Trial.
87 results